ask="3.99"
ask_size="100"
average_daily_volume="267403"
bid="3.80"
bid_size="600"
book_value="0.56"
change="-0.53"
change_from_200_day_moving_average="1.45"
change_from_50_day_moving_average="0.93"
change_from_52_week_high="-0.72"
change_From_52_week_low="1.92"
change_in_percent="-11.75%"
close="3.98"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.70"
high_52_weeks="4.70"
last_trade_date="2/23/2017"
last_trade_price="3.98"
last_trade_size="1627"
last_trade_time="4:00pm"
low="3.83"
low_52_weeks="2.06"
market_capitalization="74.37M"
moving_average_200_day="2.53"
moving_average_50_day="3.05"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+57.20%"
percent_change_from_50_day_moving_average="+30.69%"
percent_change_from_52_week_high="-15.32%"
percent_change_from_52_week_low="+93.19%"
previous_close="4.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.01"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="974738"
weeks_range_52="2.06 - 4.70"
